UnknownNot Applicable

Serratus Anterior Plane Block to Prevent Chronic Postoperative Pain in Breast Cancer

Morocco94 participantsStarted 2022-08-01

Plain-language summary

Chronic postoperative pain (CPP) remains a disturbing and obscure clinical problem. The hypothesis of this trial is that a peripheral block of the serratus anterior plane block type preoperatively after a modified radical mastectomy makes it possible to reduce the intensity and incidence of chronic post-surgical pain in breast cancer.

Who can participate

Age range

18 Years – 70 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Having an age greater than or equal to 18 years and less than 70 years * Having given written consent for participation in the study and the use of personal and medical data * Having a physical status of class I, II or III of the American Society of Anesthesiologists Exclusion Criteria: * Patients who expressed their refusal to participate in the study * Patients unable to express their non-objection to participation in the study * American Society of Anesthesiologists class \> III patients * Known allergy to local anesthetics * A contraindication to performing a peripheral nerve block (such as an acquired, constitutional or drug clotting disorder or infection at the nerve block injection site) * Morbid obesity (body mass index greater than 40 kg/m²) * Chronic use of opioids * Inability to use the patient controlled analgesia device * The existence of preoperative pain * History of neuropathy or neurological pathology * The existence of catastrophism or anxiety diagnosed preoperatively

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Chronic postoperative pain at 3 months

Timeframe: 3 months after surgery

chronic postoperative pain intensity

Timeframe: 3 months after surgery

Trial details

NCT IDNCT05494281

SponsorMoroccan Society of Surgery

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-01

Contact for this trial

Abdelilah GHANNAM, MD

+212661382585 a.ghannam@um5r.ac.ma

View on ClinicalTrials.gov More Breast Neoplasms trials